Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, is investigating whether ZimVie Inc. (“ZimVie” or the “Company”) (NASDAQ: ZIMV) and certain of its officers and directors issued false and/or misleading statements and/or failed to disclose information pertinent to investors in violation of federal securities laws. If you purchased or otherwise own ZimVie securities, and have suffered a loss, you are encouraged to contact Jonathan Zimmerman at (888) 398-9312 for more information.
ZimVie is a global life sciences leader in the dental and spine markets. In March 2022, the Company became an independent, publicly traded spin-off of the dental and spine business units of Zimmer Biomet. On March 2, 2023, ZimVie’s stock declined roughly 45% after the Company reported fourth quarter and full-year 2022 earnings that came in far below analysts’ expectations.
If you purchased or otherwise own ZimVie securities and have suffered a loss, realized or unrealized, and you wish to discuss this investigation, please contact attorney Jonathan Zimmerman at (888) 398-9312 or at email@example.com.
About Scott+Scott Attorneys at Law LLP
Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.